Sale!

POU4F3 Gene Deafness Autosomal Dominant Type 52 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POU4F3 gene plays a crucial role in the development and maintenance of hair cells in the inner ear, which are essential for hearing. Mutations in this gene can lead to autosomal dominant deafness type 52 (DFNA52), a form of progressive hearing loss that usually begins in adulthood. To diagnose this condition, individuals suspected of having DFNA52 can undergo genetic testing specifically targeting the POU4F3 gene.

DNA Labs UAE offers a specialized genetic test for identifying mutations in the POU4F3 gene associated with autosomal dominant deafness type 52. The test is comprehensive and designed to provide accurate results, aiding in the diagnosis and potential management of this hearing loss condition. The cost of the test is 4400 AED, reflecting the intricate processes and advanced technology involved in identifying the genetic mutation responsible for the condition. Undergoing this test at DNA Labs UAE ensures access to expert analysis and interpretation of the results, which can be crucial for affected individuals and their families in understanding the condition and exploring possible interventions or therapies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POU4F3 Gene Deafness autosomal dominant type 52 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS6.

Test Details

The POU4F3 gene is associated with a type of deafness called autosomal dominant type 52 (DFNA52). This type of deafness is inherited in an autosomal dominant pattern, which means that a person only needs to inherit one copy of the mutated gene from either parent to be affected. To confirm the presence of a mutation in the POU4F3 gene, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes, including POU4F3, in a single test. This test can identify specific mutations or variations in the DNA sequence of the gene, which can help diagnose DFNA52.

Genetic testing for DFNA52 can be beneficial for individuals who have a family history of deafness or for those who are experiencing hearing loss themselves. It can provide a definitive diagnosis, help determine the inheritance pattern within a family, and guide treatment options and management strategies. It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness of genetic testing, the potential risks and benefits, and the interpretation of the results. They can provide personalized guidance based on the individual’s specific situation and help make informed decisions regarding genetic testing.

Test Name POU4F3 Gene Deafness autosomal dominant type 52 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS6
Test Details

The POU4F3 gene is associated with a type of deafness called autosomal dominant type 52 (DFNA52). This type of deafness is inherited in an autosomal dominant pattern, which means that a person only needs to inherit one copy of the mutated gene from either parent to be affected.

To confirm the presence of a mutation in the POU4F3 gene, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes, including POU4F3, in a single test. This test can identify specific mutations or variations in the DNA sequence of the gene, which can help diagnose DFNA52.

Genetic testing for DFNA52 can be beneficial for individuals who have a family history of deafness or for those who are experiencing hearing loss themselves. It can provide a definitive diagnosis, help determine the inheritance pattern within a family, and guide treatment options and management strategies.

It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness of genetic testing, the potential risks and benefits, and the interpretation of the results. They can provide personalized guidance based on the individual’s specific situation and help make informed decisions regarding genetic testing.